|
|
|
Volumn 60, Issue SUPPL. 1, 1999, Pages 26-27
|
|
Pharmacoeconomics of schizophrenia in the 21st century
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
BUDGET;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE POLICY;
HUMAN;
MENTAL HEALTH CARE;
NATIONAL HEALTH SERVICE;
PARITY;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
BUDGETS;
COST-BENEFIT ANALYSIS;
DIRECT SERVICE COSTS;
DRUG COSTS;
HEALTH CARE COSTS;
HEALTH PLANNING;
HUMANS;
MASSACHUSETTS;
SCHIZOPHRENIA;
UNITED STATES;
|
|
EID: 0033045272
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
